Anita Jain - Apr 3, 2023 Form 3 Insider Report for BioXcel Therapeutics, Inc. (BTAI)

Role
10%+ Owner
Signature
/s/Anita Jain
Stock symbol
BTAI
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
3
Date filed
4/13/2023, 07:08 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BTAI Common Stock, par value $0.001 per share 550 Apr 3, 2023 Direct
holding BTAI Common Stock, par value $0.001 per share 8.55M Apr 3, 2023 By BioXcel LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

The Reporting Person may be deemed to share investment control over shares of Common Stock of the Issuer held by BioXcel LLC and held indirectly by BioXcel Holdings, Inc. The reporting person disclaims beneficial ownership of the reported securities except to the extent, if any, of the reporting person's pecuniary interest therein, and this filing shall not be deemed an admission that the Reporting Person is, for purposes of Section 16 of the Securities Exchange Act or otherwise, the beneficial owner of any such shares of Common Stock.